Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yi-Ding Chen, Ci-You Huang, Zhuo-Ping Wang & Wen Wang. (2023) Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves’ disease. Libyan Journal of Medicine 18:1.
Read now
Read now
İlkbal Temel Yüksel, Berna Aslan Çetin, Nadiye Köroğlu, Begüm Aydoğan Mathyk & Baki Erdem. (2019) Inflammatory marker YKL-40 levels in intrahepatic cholestasis of pregnancy. Gynecological Endocrinology 35:7, pages 635-637.
Read now
Read now
Articles from other publishers (35)
Wei-Li Jia, Ying-Yu Jiang, Yong Jiang, Xia Meng, Hao Li, Xing-Quan Zhao, Yi-Long Wang, Yong-Jun Wang, Hong-Qiu Gu & Zi-Xiao Li. (2023) Associations between admission levels of multiple biomarkers and subsequent worse outcomes in acute ischemic stroke patients. Journal of Cerebral Blood Flow & Metabolism.
Crossref
Crossref
Nora Sipeki, Patricia Julianna Kovats, Claudia Deutschmann, Peter Schierack, Dirk Roggenbuck & Maria Papp. (2023) Location-based prediction model for Crohn’s disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies. World Journal of Gastroenterology 29:42, pages 5728-5750.
Crossref
Crossref
Debjani Guha, Vikas Misra, Jun Yin, Miki Horiguchi, Hajime Uno & Dana Gabuzda. (2023) Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS.
Crossref
Crossref
Caoyang Fang, Jun Li, Wei Wang, Yuqi Wang, Zhenfei Chen & Jing Zhang. (2023) Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction. Frontiers in Medicine 10.
Crossref
Crossref
Rahim Kocabas. (2023) Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model. Korean Circulation Journal 53:2, pages 92.
Crossref
Crossref
Yinghong Tang, Mengdi Du, Wei Qian, Fengyun Lu, Jiayi Dai, Xiaoqing Qi, Wangyan Liu, Changjing Feng, Xiaoxuan Sun, Yinsu Zhu, Qiang Wang & Lei Zhou. (2022) The diagnostic value of serum YKL-40 for myocardial involvement in idiopathic inflammatory myopathy. Clinica Chimica Acta 537, pages 167-172.
Crossref
Crossref
Buğra Kerget, Hatice Beyza Özkan, Dursun Erol Afşin, Abdullah Osman Koçak, Esra Laloglu, Elif Yılmazel Uçar & Leyla Sağlam. (2022) Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism. Clinical Biochemistry 108, pages 20-26.
Crossref
Crossref
Krzysztof Laudanski, Da Liu, Tony Okeke, Mariana Restrepo & Wilson Y. Szeto. (2022) Persistent Depletion of Neuroprotective Factors Accompanies Neuroinflammatory, Neurodegenerative, and Vascular Remodeling Spectra in Serum Three Months after Non-Emergent Cardiac Surgery. Biomedicines 10:10, pages 2364.
Crossref
Crossref
Caoyang Fang, Zhenfei Chen, Jing Zhang, Jianyuan Pan, Xiaoqin Jin, Mengsi Yang & Luyao Huang. (2022) The Value of Serum YKL-40 and TNF-α in the Diagnosis of Acute ST-Segment Elevation Myocardial Infarction. Cardiology Research and Practice 2022, pages 1-7.
Crossref
Crossref
Henrik B. Krarup, Karsten F. Rex & Stig Andersen. (2022) Mortality in Greenlanders with chronic hepatitis B virus infection. Journal of Viral Hepatitis 29:6, pages 432-437.
Crossref
Crossref
Yu Lu, Na Chang, Xinhao Zhao, Renmin Xue, Jing Liu, Lin Yang & Liying Li. (2022) Activated Neutrophils Secrete Chitinase-Like 1 and Attenuate Liver Inflammation by Inhibiting Pro-Inflammatory Macrophage Responses. Frontiers in Immunology 13.
Crossref
Crossref
Xiaoting Huang, Jialing Zhuang, Yongqiang Yang, Jiaxin Jian, Wen Ai, Chunyong Liu, Wenzhi Tang, Changyu Jiang, Yongshen He, Lesheng Huang & Se Peng. (2022) Diagnostic Value of Serum Chitinase-3-Like Protein 1 for Liver Fibrosis: A Meta-analysis. BioMed Research International 2022, pages 1-13.
Crossref
Crossref
Norihisa Nishimura, Davide De Battista, David R. McGivern, Ronald E. Engle, Ashley Tice, Rafaelle Fares-GusmaoJuraj KabatAnna PomerenkeHanh Nguyen, Shinya SatoKevin W. Bock, Ian N. MooreDavid E. KleinerFausto ZamboniHarvey J. AlterSugantha Govindarajan & Patrizia Farci. (2021) Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis. Proceedings of the National Academy of Sciences 118:17.
Crossref
Crossref
Qiuli Liu, Xiaoyong Chen, Chang Liu, Lijie Pan, Xinmei Kang, Yanli Li, Cong Du, Shuai Dong, Andy Peng Xiang, Yan Xu & Qi Zhang. (2021) Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Cell Death & Disease 12:3.
Crossref
Crossref
Samaneh Kamalipooya, Reza Zarezadeh, Zeinab Latifi, Mohammad Nouri, Amir Fattahi & Zahra Salemi. (2021) Serum transforming growth factor β and leucine-rich α-2-glycoprotein 1 as potential biomarkers for diagnosis of uterine leiomyomas. Journal of Gynecology Obstetrics and Human Reproduction 50:3, pages 102037.
Crossref
Crossref
Yu Wang, Bohong Li, Yong Jiang, Runhua Zhang, Xia Meng, Xingquan Zhao, Yongjun Wang, Xihai Zhao & Gaifen Liu. (2021) YKL-40 Is Associated With Ultrasound-Determined Carotid Atherosclerotic Plaque Instability. Frontiers in Neurology 12.
Crossref
Crossref
Songhua Zhang, Aryanna Sousa, Mengqui Lin, Ayako Iwano, Rishubh Jain, Bing Ma, Chang Min Lee, Jin Wook Park, Suchitra Kamle, Rolf Carlson, Ghun Geun Lee, Jack A. Elias & Jack R. Wands. (2021) Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease. Cells 10:2, pages 201.
Crossref
Crossref
Rucsanda PinteacXavier MontalbanManuel Comabella. (2021) Chitinases and chitinase-like proteins as biomarkers in neurologic disorders. Neurology Neuroimmunology & Neuroinflammation 8:1.
Crossref
Crossref
Eric A. Hoste, Suvi T. Vaara, Jorien De Loor, Mikko Haapio, Lieve Nuytinck, Kristel Demeyere, Ville Pettilä & Evelyne Meyer. (2020) Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 (CHI3L1) to detect acute kidney injury in the critically ill: a post hoc laboratory analysis on the FINNAKI cohort. Critical Care 24:1.
Crossref
Crossref
Yingjian Deng, Guiyang Li, Dong Chang & Xin Su. (2020) YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clinica Chimica Acta 511, pages 40-46.
Crossref
Crossref
Camilla Bjørnbak Holst, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Petra Hamerlik, Hans Skovgaard Poulsen & Julia Sidenius Johansen. (2020) Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40. Frontiers in Oncology 10.
Crossref
Crossref
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud & Jens Kastrup. (2020) Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease. Journal of the American Heart Association 9:5.
Crossref
Crossref
Camilla Palmquist, Christian Dehlendorff, Dan Calatayud, Carsten Palnæs Hansen, Jane Preuss Hasselby & Julia Sidenius Johansen. (2020) Prediction of Unresectability and Prognosis in Patients Undergoing Surgery on Suspicion of Pancreatic Cancer Using Carbohydrate Antigen 19-9, Interleukin 6, and YKL-40. Pancreas 49:1, pages 53-61.
Crossref
Crossref
Hafsa Ismail, Jens Helby, Lisbet R. Hölmich, Annette H. Chakera, Lars Bastholt, Helle Klyver, Pia Sjøgren, Henrik Schmidt, Liv Schöllhammer, Julia S. Johansen, Børge G. Nordestgaard & Stig E. Bojesen. (2019) Measured and genetically predicted plasma YKL-40 levels and melanoma mortality. European Journal of Cancer 121, pages 74-84.
Crossref
Crossref
Dina Nada, Cédric Julien, Pierre H. Rompré, Marie-Yvonne Akoume, Kristen F. Gorman, Mark E. Samuels, Emile Levy, Jason Kost, Dawei Li & Alain Moreau. (2019) Association of Circulating YKL-40 Levels and CHI3L1 Variants with the Risk of Spinal Deformity Progression in Adolescent Idiopathic Scoliosis. Scientific Reports 9:1.
Crossref
Crossref
Luyu Yang, Hui Dong, Huizhi Lu, Youxia Liao, Hao Zhang, Lingwen Xu, Yun Tan, Song Cao, Jinhui Tan & Shouzhi Fu. (2019) Serum YKL-40 predicts long-term outcome in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Medicine 98:12, pages e14920.
Crossref
Crossref
Milad Zadi Heydarabad, Sina Baharaghdam, Ako Azimi, Hamed Mohammadi, Jamal Eivazi Ziaei, Behruz Yazdanpanah, Mohsen Sharif Zak, Mohammad Esfini Farahani, Aghdas Dohrabpour, Nasim Partash & Mehdi Talebi. (2018) The role of tumor suppressor of resveratrol and prednisolone by downregulation of YKL‐40 expression in CCRF‐CEM cell line. Journal of Cellular Biochemistry 120:3, pages 3773-3779.
Crossref
Crossref
Meghan A. Bowler, Matthew R. Bersi, Larisa M. Ryzhova, Rachel J. Jerrell, Aron Parekh & W. David Merryman. (2018) Cadherin-11 as a regulator of valve myofibroblast mechanobiology. American Journal of Physiology-Heart and Circulatory Physiology 315:6, pages H1614-H1626.
Crossref
Crossref
Unnur Dilja Teitsdottir, Erna Sif Arnardottir, Erla Bjornsdottir, Thorarinn Gislason & Petur Henry Petersen. (2018) Obesity modulates the association between sleep apnea treatment and CHI3L1 levels but not CHIT1 activity in moderate to severe OSA: an observational study. Sleep and Breathing 22:4, pages 1101-1109.
Crossref
Crossref
Clemens Höbaus, Maximilian Tscharre, Carsten Thilo Herz, Gerfried Pesau, Thomas Wrba, Renate Koppensteiner & Gerit-Holger Schernthaner. (2018) YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients. Atherosclerosis 274, pages 152-156.
Crossref
Crossref
Beatriz A. Sánchez-Jiménez, Diana Brizuela-Alcántara, Martha H. Ramos-Ostos, Luis F. Alva-López, Misael Uribe-Esquivel & Norberto C. Chávez-Tapia. (2018) Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis. Alcohol 69, pages 63-67.
Crossref
Crossref
Yeşim YENER & Fatma Hümeyra YERLİKAYA. (2018) Western diet induces endogen oxidative deoxyribonucleic acid damage and infl ammation in Wistar rats. Revista de Nutrição 31:3, pages 263-273.
Crossref
Crossref
Frederik Persson & Rikke Borg. (2018) YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology. Kidney International 93:1, pages 21-22.
Crossref
Crossref
X.-L. Chen, Q. Li, W.-S. Huang, Y.-S. Lin, J. Xue, B. Wang, K.-L. Jin & B. Shao. (2017) Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurologica Scandinavica 136:2, pages 97-102.
Crossref
Crossref
Yinghong Tang, Mengdi Du, Wei Qian, Fengyun Lu, Jiayi Dai, Xiaoqing Qi, Wangyan Liu, Changjing Feng, Xiaoxuan Sun, Yinsu Zhu, Qiang Wang & Lei Zhou. (2022) The Diagnostic Value of Serum YKL-40 for Myocardial Involvement in Idiopathic Inflammatory Myopathy. SSRN Electronic Journal.
Crossref
Crossref